An Analysis of Phenotypic Variation in the Familial Cancer Syndrome von Hippel–Lindau Disease: Evidence for Modifier Effects

This publication has 37 references indexed in Scilit:

• Increased risk for hepatocellular carcinoma in NAT2-slow acetylators and CYP2D6-rapid metabolizers
  Pharmacogenetics, 1996
• Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis
  Human Molecular Genetics, 1996
• CYP2D6 genes and risk of liver cancer
  The Lancet, 1995
• Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotype
  Human Mutation, 1995
• Mutations of the VHL tumour suppressor gene in renal carcinoma
  Nature Genetics, 1994
• Detailed mapping of germline deletions of the von Hippel—Lindau disease tumour suppressor gene
  Human Molecular Genetics, 1994
• Polymorphism in CYP1A1 and CYP2D6 genes: possible association with susceptibility to lung cancer.
  Environmental Health Perspectives, 1993
• Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
  Science, 1993
• Molecular genetic analysis of the cytochrome P450-debrisoquine hydroxylase locus and association with cancer susceptibility.
  Environmental Health Perspectives, 1992
• Mutation and Cancer: Statistical Study of Retinoblastoma
  Proceedings of the National Academy of Sciences, 1971